EC Number   |
Inhibitors |
Structure |
|---|
   3.4.23.32 | more |
diazoacetyl-DL-norleucine methyl ester; diisopropyl fluorophosphate; EDTA; methyl 2-diazoacetamidohexanoate; microbial proteinase inhibitors (metal proteinase inhibitor, serine proteinase and thiol proteinase inhibitor); not: pepstatin Ac; PCMB; PMSF; Streptomyces-pepsin inhibitor (S-PI) |
 |
| 3.4.23.32 | more |
diazoacetyl-DL-norleucine methyl ester; methyl 2-diazoacetamidohexanoate; not: pepstatin Ac; Streptomyces-pepsin inhibitor (S-PI) |
|
| 3.4.23.32 | more |
the enzyme is insensitive to pepstatin and inhibitor S-PI, i.e. Ac-VV-statine-A-statine, statine is 4-amino-3-hydroxy-6-methylheptanoic acid, no inhibition by diazoacetyl-DL-norleucine methyl ester |
|
| 3.4.23.32 | N-bromosuccinimide |
- |
  |
| 3.4.23.32 | NaCl |
a substantial decrease of the SGP catalytic efficiency (kcat/Km) is observed as the NaCl concentration is increases up to 1 M, while in the range up to 200 mM NaCl the effect is mainly in Km because there is no significant decrease in kcat values. A significant decrease in the kcat values is observed as the salt concentration is further increased from 200 to 800 mM NaCl |
|
